Global Stents Market Analysis and Size

Global Stents Market
The Stents Market growth at a CAGR of 5.73% & expected USD 18627.74 million by 2029. It is analyzed as product, type, material and end user by forecast trends to 2029.

Industry Overview

The market for stents was worth over USD 8.6 billion in 2021, and it is expected to expand by 4% between 2022 and 2028 as a result of the quick development of technology that has led to high precision and enhanced dependability in stents. The market value will also increase as a result of cutting-edge advances in drug-eluting stents including bifurcation stents and biodegradable materials.

Additionally, regular technological advancements enable the development of less invasive stents, supporting market expansion. To satisfy the growing requirements of patients, various market participants are also concentrating on the development of minimally invasive stents.

Stents are small plastic or metal tubes used to maintain the opening of an anatomical artery or duct. Stents are utilized in operations for conditions like deep vein thrombosis, peripheral artery disease, and coronary heart disease, among others.

Market Analysis and Size

Stents are regarded as the biggest stents and are frequently used to clear blockages from bigger arteries. These stents guard against aneurysm ruptures in the aorta, brain, or other blood arteries. The market for stents is expanding quickly because of technological advancements.

During the forecast period of 2022–2029, the global stents market is projected to grow at a CAGR of 5.73% from its 2021 market value of USD 11656.72 million to USD 18627.74 million. The Data Bridge Market Research team’s thorough expert research, patient epidemiology, pipeline analysis, price analysis, and regulatory framework are all included in the market study.

Global Stents Market: Definition

A stent is a type of medical device that is used to keep a blocked route open. This medical device, which can be constructed of plastic or metal, is shaped like a thin tube that helps to restore the flow of blood and other bodily fluids to various organs.

Report Scope and Market Segmentation

Forecast Period 2022 to 2029
Base Year 2021
Historic Years 2020 (Customizable to 2019 – 2014)
Quantitative Units Revenue in USD Million, Volumes in Units, Pricing in USD
Segments Covered Product (Coronary Stents, Peripheral Stents, Neurovascular stents, Stent-Related), Type (Self-Expandable Stents, Balloon-Expandable Stents), Material (Metallic, Polymer, Natural), End User (Hospitals, Ambulatory Surgical Centres, Others)
Countries Covered U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered Boston Scientific Corporation (US), BD (US), Medtronic (Ireland), Abbott (US), Cook (US), Merit Medical Systems (US), Novatech SA (France), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), Fuji Systems Corp. (Tokyo), MICRO-TECH EUROPE (Germany), Vascular Concepts (India), Olympus (Japan), W. L. Gore & Associates Inc. (US), B. Braun Melsungen AG (Germany), Meditek Systems Pvt. Ltd. (India), Biotronik SE & Co. KG (Germany), Teleflex Incorporated (US), and Thoracent, Inc. (US), among others
Market Opportunities
  • Increase in the prevalence of coronary artery disease
  • Surge in funding
  • Advancements in medical devices

For More Details Visit:

Covid-19 Impact on Stents Market

Due to the decrease in elective procedures, COVID-19 had a detrimental effect on the stents market. O&P clinics were briefly shuttered during the epidemic, and hospital access was limited to non-essential care. Social exclusion, population control, and restricted access to clinics all had a significant impact on the market. The market growth was also influence by the slowdown in patient flow, referrals, trauma, and industrial injuries. The market will, however, start to expand again after the epidemic since the prior limits have been loosened.

The COVID-19 epidemic has caused disruption in the healthcare industry and reduced market share for stents globally. The healthcare system was affect by the rising number of COVID-19 cases throughout the world, which led to considerable delays in non-essential procedures and the detection of non-emergency illness problems. The severely enforced lockdown also caused disruptions in the supply and manufacturing chains, which resulted in a constrained supply of stents for end users. The movement of people and products was restricted, and non-essential medical operations including angioplasty and bypass surgery were stopped.

Therefore, the aforementioned factors had a negative impact on the expansion of the global stents market. Additionally, a number of manufacturers and other industry participants the significant market rebound in 2021 when non-essential processes were restarted and the limitations were loosened internationally. As a result, it was highlighted that the COVID-19 pandemic had a negative effect in the early years, but a strategic recovery is anticipated to put the market back on track in the following years.

Global Stents Market Scope and Market Size

Market for stents is divide into product, type, material, and end user segments. You may examine the industries’ slow-growing segments using the growth of these segments, and you can give users a useful market overview and industry insights to aid in their strategic decision-making for finding key market applications.


  • Coronary Stents
  • Peripheral Stents
  • Neurovascular Stents
  • Stent-Related

The stents market is divide into four product categories: coronary stents, peripheral stents, neurovascular stents, and stent-related. Further categorization of coronary stents includes bare metal, drug-eluting, and bio resorbable stents. A further division of peripheral stents includes iliac, femoral-popliteal, renal, and carotid stents. Vena cava filters and synthetic grafts have been included in the segmentation of stent-related items.

Some of the recent industry developments:

A novel radial to periphery self-expanding stent from Terumo will go on sale in September 2019. This stent is intend for PAD procedures above the knee. Rapid Exchange (RX) technology is use in it.

  • iVascular’s Balloon-expanding (BX) covered stent, iCover, was given CE mark clearance. It is used to treat ruptures and aneurysms as well as arteriosclerotic lesions in the iliac and renal arteries. The company was able to grow because of this tactic.
  • The National Medical Products Administration (NMPA) of China has granted Micro Port Scientific a registration certificate for their Bridge vertebral drug-eluting stent, the company reported. The gadget has a novel drug delivery system that enables quicker endothelialization and lower thromboembolic and restenosis occurrences. The company’s market presence is strengthened by the approval.

Stents Market Dynamics

Understanding market drivers, benefits, opportunities, restrictions, and challenges is the focus of this section. The whole discussion of all of this is provided below:

  • Coronary Artery Disease Prevalence

One of the key reasons propelling the growth of the stents market is the rise in the prevalence of coronary artery disease.

  • Minimally invasive surgery is preferred

Because of benefits like rapid recovery and less discomfort, minimally invasive surgery is becoming more and more popular, which spurs market expansion.

  • A Rise in Resources

The market is also influenced by the increase of investment from both public and private entities for the growth of the healthcare industry.

  • Opportunities

Furthermore, throughout the projection period of 2022 to 2029, improvements in medical devices provide lucrative prospects to market participants. Additionally, bioresorbable vascular scaffolds will boost market growth.

Stents Market Regional Analysis/Insights

The stents market is analyze, and insights and trends on market size are provide by nation, product, type, material, and end user.

The United States, Canada, and Mexico make up North America, while Germany, France, the United Kingdom, the Netherlands, Switzerland, Belgium, Russia, Italy, Spain, and Turkey make up Europe. Other countries covered in the stents market report include China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and the rest of Asia-Pacific (APAC). Saudi Arabia, the United Arab Emirates, South Africa, Egypt, Israel, and the rest of Middle East and Africa (MEA) make

Due to the prevalence of obesity and other cardiovascular illnesses brought on by sedentary lifestyles in the area, North America dominates the global stent market.

Due to the region’s rising healthcare awareness, Asia-Pacific (APAC) is predicted to experience considerable growth from 2022 to 2029.

The national part of the research also lists specific market-impacting variables and domestic market regulatory changes that have an effect on the market’s present and future tendencies.


Please enter your comment!
Please enter your name here